Skip to main content

Advertisement

Table 3 Immunoprophylaxis used in children with HBV infection or resolved infection*

From: Gaps in the prevention of perinatal transmission of hepatitis B virus between recommendations and routine practices in a highly endemic region: a provincial population-based study in China

Child** HBIG (doses) Vaccination
Doses 1st 2nd (m) 3rd (m)
Children with positive HBsAg
A 2 3 24 h 1 6
B 2 3 2 m 5 unknown
C 2 3 1 m 2 7
D 0 3 7 d 1 6
E 0 3 24 h 1 6
F 0 3 24 h 1 6
G 0 3 24 h 1 6
H 0 3 24 h 1 6
I 0 3 24 h 1 6
J 0 3 24 h 1 6
K 0 3 24 h 1 6
Children with negative HBsAg and positive anti-HBc
a 2 3 24 h 1 6
b 2 3 24 h 1 6
c 2 3 24 h 1 6
d 1 3 24 h 1 6
e 1 3 24 h 1 6
f 1 3 24 h 1 6
g 1 3 24 h 1 6
h 0 3 24 h 1 6
i 0 3 24 h 1 6
j 0 3 24 h 1 6
k 0 3 24 h 1 6
l 0 3 40 d 2 5
m 0 2 24 h 1
n 0 3 24 h 1 6
o 0 3 24 h 1 6
p 0 3 24 h 1 6
  1. *Mothers of children A–K and a–l were positive for both HBsAg and HBeAg, and mothers of children m–p were positive for HBsAg and negative for HBeAg.
  2. **Children a–j and l–n were also positive for anti-HBs, and children k, o, and p were negative for anti-HBs.